Atlas Trials

An Efficacy Trial of Low Dose All-trans Retinoic Acid in Patients With Primary Sclerosing Cholangitis

Clinical trial NCT03359174 · TERMINATED

Trial details

NCT number
NCT03359174
Sponsor
Yale University
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Cholangitis, Sclerosing
Start date
2018-05-29
Primary completion
2020-12-01
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.